Background Sleep disturbance is a prominent symptom of atopic dermatitis (AD) and can
result in insomnia, daytime fatigue, drowsiness, reduced productivity and impaired quality of …

Atopic dermatitis (AD) is a chronic, heterogeneous, inflammatory disease characterized by
skin lesions, pruritus, and pain. Patients with moderate-to-severe AD experience chronic …

Abstract The International Society of AD (ISAD) organized a roundtable on global aspects of
AD at the WCD 2023 in Singapore. According to the Global Burden of Disease (GBD) …

Background Atopic dermatitis (AD) is associated with altered skin barrier, microbiome, and
immune dysregulation that may increase risk of skin infections. Objective The aim of the …

Atopic dermatitis (AD) is one of the most common chronic inflammatory skin diseases, and
the condition is typified by barrier dysfunction and immune dysregulation. Recent studies …

Introduction Patients with eczema suffer from high psychological burden, often caused and
exacerbated by chronic pruritus, which leads to a vicious itch-scratch cycle. Although much …

Skin of color (SOC) populations include those who identify as Black/African, Hispanic/Latinx,
Asian/Pacific Islander, American Indian/Native Alaskan, Indigenous Australian, Middle …

Background Moderate-to-severe atopic dermatitis (AD) is inadequately controlled with
current treatments for many patients. Abrocitinib is an oral Janus kinase 1 selective inhibitor …

Despite skin being the largest and most exposed organ of the human body, skin issues can
be challenging to diagnose in deployed military service members. Common reasons …

Background Patients with atopic dermatitis (AD) have heterogeneous clinical phenotypes,
including different combinations of itch and lesional severity. Little is known about the …